
Equity benchmarks closed higher amid consolidation on February 6 after a day of correction, while market breadth remained negative. About 1,673 shares declined against 1,207 advancing shares on the NSE. The market may maintain a positive trend following the announcement of the interim trade agreement between the US and India. Below are some short-term trading ideas to consider:
Rajesh Palviya, Senior Vice President Research (Head Technical Derivatives) at Axis Securities
Amber Enterprises India | CMP: Rs 6,640

On the weekly chart, Amber Enterprises has staged a sharp recovery from the Rs 5,400–5,500 support zone, breaking out above the descending trendline that guided its recent correction. This reversal is accompanied by a significant uptick in trading volumes, signalling a shift in sentiment and fresh accumulation at lower levels.
The weekly RSI (14) has surged from oversold territory and is now trending upwards near 47, reflecting a strong recovery in momentum. The breakout from the falling channel suggests that the “lower high, lower low” sequence has been disrupted, paving the way for further gains.
Strategy: Buy
Target: Rs 7,000, Rs 7,400
Stop-Loss: Rs 6,300
FSN E-Commerce Ventures Nykaa | CMP: Rs 277

On the weekly chart, Nykaa is trending within a well-defined medium-term rising channel and has recently bounced off the lower trendline support near the Rs 235 level. It has staged a decisive breakout above the crucial horizontal resistance at Rs 272, supported by a significant surge in trading volumes, which signals strong bullish momentum and accumulation.
The weekly structure shows the stock consistently making higher highs and higher lows, confirming a robust primary uptrend. The weekly RSI (14) has also turned upwards and is currently trading around 62.93, suggesting that momentum is strengthening and heading toward the overbought zone, reinforcing the positive bias.
Strategy: Buy
Target: Rs 300, Rs 320
Stop-Loss: Rs 270
HDFC Asset Management Company | CMP: Rs 2,719.8

On the weekly chart, HDFC AMC broke above a descending channel that was in formation, hitting an all-time high of Rs 2,974 in October 2025, with a strong bullish candle indicating the onset of a medium-term uptrend. The stock found support at the 50 percent Fibonacci retracement of the rally from February to October 2025 at Rs 2,389 and bounced back. A strong recovery from this level, backed by volume expansion, indicates renewed market participation.
The stock is currently attempting to break above its immediate trendline resistance, which would signal a potential reversal of the short-term bearish trend. The weekly RSI (14) is currently positioned at 54.5 and has broken above its downward-sloping trendline and reference line, generating a buy signal. Additionally, the stock remains positioned above its key 20-, 50-, 100-, and 200-day simple moving averages, reinforcing the primary bullish structure.
Strategy: Buy
Target: Rs 2,900, Rs 3,000
Stop-Loss: Rs 2,660
Osho Krishan, Chief Manager - Technical & Derivative Research at Angel One
Emcure Pharmaceuticals | CMP: Rs 1,515.7

Emcure Pharmaceuticals has been in a secular uptrend, hovering above all its significant EMAs on the daily chart, with a higher-high formation. The technical structure appears positive, with the SuperTrend indicator favouring bullish price action.
Additionally, the stock has rebounded after testing the neckline of a consolidation breakout on the daily chart, adding to the bullish quotient. Hence, buying Emcure Pharmaceuticals is recommended around Rs 1,500.
Strategy: Buy
Target: Rs 1,620, Rs 1,640
Stop-Loss: Rs 1,430
Schaeffler India | CMP: Rs 3,814.3

Schaeffler India has been in a corrective phase until it tested the 50 percent Fibonacci retracement, which was identified as a strong demand zone, and subsequently showcased a robust rebound on the weekly chart. Moreover, the recent traction from the support zone and oversold territory portrays an early signal of reversal in the near term.
Additionally, the 14-week RSI and MACD histograms are both aligned with the pullback momentum in the counter, suggesting a strong risk-reward ratio. Hence, buying Schaeffler India is recommended around Rs 3,800–3,770.
Strategy: Buy
Target: Rs 4,100, Rs 4,160
Stop-Loss: Rs 3,580
Navin Fluorine International | CMP: Rs 6,417.5

Navin Fluorine has demonstrated a substantial consolidation breakout after an elongated period, propelling the stock above all its significant EMAs and indicating a bullish bias. Additionally, the SuperTrend has turned bullish, signalling a buy, and the volume spurt has added conviction.
The technical indicators are also strongly aligned with the price momentum, indicating a bullish outlook for the near term. Hence, buying Navin Fluorine on dips around Rs 6,350–6,300 is recommended.
Strategy: Buy
Target: Rs 7,000
Stop-Loss: Rs 5,800
Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.